4//SEC Filing
Wenqing Yao 4
Accession 0001209191-21-045892
CIK 0000879169other
Filed
Jul 6, 8:00 PM ET
Accepted
Jul 7, 5:54 PM ET
Size
11.2 KB
Accession
0001209191-21-045892
Insider Transaction Report
Form 4
INCYTE CORPINCY
Wenqing Yao
Ex VP Discovery Medicinal Chem
Transactions
- Award
Employee Stock Option (right to buy)
2021-07-02+15,054→ 15,054 totalExercise: $83.58Exp: 2031-07-01→ Common Stock (15,054 underlying) - Tax Payment
Common Stock
2021-07-02$83.58/sh−2,953$246,812→ 98,980 total - Award
Common Stock
2021-07-02+7,853→ 101,933 total - Tax Payment
Common Stock
2021-07-06$83.34/sh−405$33,753→ 98,575 total
Footnotes (4)
- [F1]Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years, subject to Wenqing Yao's continued service with the issuer through the applicable vesting dates. The RSUs may be settled only for shares of common stock on a one-for-one basis.
- [F2]Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units or earned performance shares previously reported in Table I as common stock.
- [F3]Including the July 2, 2021 Restricted Stock Unit Grant, this includes an aggregate of 58,773 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested.
- [F4]Beginning July 2, 2021, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.
Documents
Issuer
INCYTE CORP
CIK 0000879169
Entity typeother
Related Parties
1- filerCIK 0001624033
Filing Metadata
- Form type
- 4
- Filed
- Jul 6, 8:00 PM ET
- Accepted
- Jul 7, 5:54 PM ET
- Size
- 11.2 KB